Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
New immunization study results from University of Texas described
April 8th, 2009
According to a study from the United States, "Mice deficient in B cells (mu mT mice) were used to evaluate the role of antibody in enhanced chlamydial clearance and reduction of pathology afforded by vaccination with recombinant chlamydial protease-like activity factor (rCPAF)." "Enhanced, but comparable, chlamydial clearance was observed in mu mT and wild-type (WT) mice after rCPAF+CpG vaccination. Chlamydia-induced pathology was present in mock-immunized animals, but at significantly greater levels in mu mT than WT mice, whereas vaccinated mu mT and WT mice exhibited similar reductions in pathology," wrote A.K. Murthy and colleagues, University of Texas. ...
Source: Vaccine Weekly (2009-04-08)
|
